Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $53000.0.

  • Arcadia Biosciences' Share-based Compensation fell 6580.65% to $53000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $334000.0, marking a year-over-year decrease of 3803.34%. This contributed to the annual value of $512000.0 for FY2024, which is 2859.14% down from last year.
  • As of Q3 2025, Arcadia Biosciences' Share-based Compensation stood at $53000.0, which was down 6580.65% from $86000.0 recorded in Q2 2025.
  • Arcadia Biosciences' Share-based Compensation's 5-year high stood at $506000.0 during Q4 2021, with a 5-year trough of $53000.0 in Q3 2025.
  • In the last 5 years, Arcadia Biosciences' Share-based Compensation had a median value of $199000.0 in 2023 and averaged $215421.1.
  • In the last 5 years, Arcadia Biosciences' Share-based Compensation surged by 15555.56% in 2021 and then plummeted by 6580.65% in 2025.
  • Quarter analysis of 5 years shows Arcadia Biosciences' Share-based Compensation stood at $506000.0 in 2021, then crashed by 58.7% to $209000.0 in 2022, then crashed by 31.1% to $144000.0 in 2023, then decreased by 18.75% to $117000.0 in 2024, then crashed by 54.7% to $53000.0 in 2025.
  • Its Share-based Compensation stands at $53000.0 for Q3 2025, versus $86000.0 for Q2 2025 and $78000.0 for Q1 2025.